Insights
Search Results
Client Highlights
2.11.26
Wilson Sonsini Secures HKIAC Arbitration Victory for Clients
On February 6, 2026, the Hong Kong International Arbitration Centre (HKIAC) issued a partial award (the Partial Award) in a dispute between Leed Education Holding Limited, National Education Holding Limited, and Hyde Education Holding Limited (collectively, the Claimants) and Minsheng Vocational Education Company Limited (the Respondent), a subsidiary of Minsheng Education Group Company Limited (Minsheng Education). Wilson Sonsini represents the Claimants in the arbitration.
Client Highlights
7.03.25
Wilson Sonsini Secures Refusal of Application for Urgent Anti-Suit Injunction on Behalf of Sinovac at Hong Kong High Court
On June 27, 2025, Deputy High Court Judge Jonathan Wong of the High Court of Hong Kong ruled in favor of Sinovac Biotech, Ltd. (Sinovac), 1Globe Capital LLC (1Globe), and OrbiMed Partners Master Fund Limited (OrbiMed), refusing Prime Success, L.P.’s ex parte application for urgent injunctive relief in aid of arbitration. The court also declined an application by Vivo Capital, LLC and its affiliates to join the ex parte application.
Client Highlights
2.03.25
Wilson Sonsini Successfully Represents Impossible Foods in First-of-Its-Kind FoodTech Patent Suit
Wilson Sonsini served as lead counsel for Impossible Foods in a patent infringement litigation alleging infringement of seven Impossible Foods patents covering manufacturing processes, ingredients, and finished products relating to plant-based food containing heme and Impossible’s innovative transgenic yeast used to manufacture that heme. Our team successfully represented Impossible Foods in defense of six inter partes review petitions before the Patent Trial and Appeal Board in 2022 and 2023. Wilson Sonsini defeated the defendant’s motion to dismiss and motion to stay the District Court litigation. The matter was closely watched as the first patent infringement case in the burgeoning foodtech industry. With trial approaching, the parties resolved the matter and released a joint statement that said: “This resolution affirms Impossible Foods’ category leadership and the strength of its product portfolio related to heme.”
Client Highlights
11.04.24
Wilson Sonsini Secures Total Victory for Inhibrx Biosciences in Trade Secret Misappropriation Trial
On November 1, 2024, a federal jury in Delaware unanimously returned a verdict for Wilson Sonsini clients Inhibrx Biosciences and Dr. Brendan Eckelman. Inhibrx and its co-founder, Dr. Eckelman, are at the forefront of developing innovative therapies to combat cancer using the body’s own immune system. Their novel antibodies aim to both inhibit tumor growth and stimulate immune response.
Client Highlights
8.23.24
Wilson Sonsini Secures Complete Victory for Scale Computing in Patent Infringement Trial
On August 22, 2024, Wilson Sonsini Goodrich & Rosati secured a complete jury victory in a patent infringement trial in the U.S. District Court for the District of Delaware on behalf of firm client Scale Computing, Inc. Following a four-day trial, the jury unanimously found that Scale Computing’s accused products, including the Scale Computing Platform and its Scale Computing Reliable Independent Block Engine (SCRIBE), did not directly or indirectly infringe DataCore Software Corp.’s data storage patent (U.S. Patent No. 9,344,235). The jury also found all of DataCore’s asserted claims invalid as anticipated by the prior art.
Client Highlights
4.03.24
Cayman Court of Appeal Dismisses Appeal Against Interim Quia Timet Injunction Granted Pursuant to Section 54 of Arbitration Act
The Court of Appeal of the Cayman Islands Reaffirms Ruling of the Grand Court of the Cayman Islands and Provides Further Guidance on the Interpretation of Section 54 of the Arbitration Act
Bylined Articles
9.05.19
Litigation & Dispute Resolution – U.S. Chapter (2019)
The American legal system, founded on notions of fairness and due process, is respected throughout the world for its ability to deliver predictable, equitable, and efficient justice. It employs an adversarial model to reach the truth of a matter wherein each litigating party (rather than the court or special prosecutor) bears the responsibility to prove its own case to a jury and/or impartial judge by producing and challenging evidence and legal arguments.
Bylined Articles
8.11.17
Litigation and Dispute Resolution – U.S. Chapter (2017)
The American legal system, founded on notions of fairness and due process, is respected throughout the world for its ability to deliver predictable, equitable, and efficient justice. It employs an adversarial model to reach the truth of a matter wherein each litigating party (rather than the court or special prosecutor) bears the responsibility to prove its own case to a jury and/or impartial judge by producing and challenging evidence and legal arguments.
Alerts
7.14.17
Recent $455 Million Payment Reaffirms Certainty of International Arbitral Awards
One of the most often overlooked features of arbitration in the context of international commercial disputes is the certainty provided by a final award. Recently, Dow Agrosciences paid Bayer Cropscience more than $455 million to satisfy an arbitral award rendered by an International Chamber of Commerce (ICC) tribunal. On July 6, 2017, the U.S. District Court for the Eastern District of Virginia released the supersedeas bond securing that payment.1
Bylined Articles
8.19.16
Litigation and Dispute Resolution -- U.S. Chapter (2016)
The American legal system, founded on notions of fairness and due process, is respected throughout the world for its ability to deliver predictable, equitable, and effi cient justice. It employs an adversarial model to reach the truth of a matter wherein each litigating party (rather than the court or special prosecutor) bears the responsibility to prove its own case to a jury and/or impartial judge by producing and challenging evidence and legal arguments.